NeoGenomics Laboratories · 1 day ago
Temporary Contract Analyst
United States
Contract
Remote
Entry Level
1+ years expNeoGenomics Laboratories is a company focused on improving patient care through exceptional work in the field of cancer reference laboratory services. They are seeking a Temporary Contract Analyst to review and analyze contracts, ensuring the contract database is accurate and compliant to support efficient business operations.
BiotechnologyGeneticsHealth CareHealth DiagnosticsMedicalPharmaceutical
Responsibilities
Review and analyze a variety of existing contracts, including service agreements, supplier contracts to identify and extract essential details
Extract and organize key contract data, such as start and end dates, renewal terms, payment schedules, termination clauses, obligations, deliverables, and any associated risks or compliance requirements
Input extracted data accurately into the Contract Management System, ensuring data integrity, consistency, and adherence to company standards
Verify data accuracy by cross-referencing contract documents with system entries and resolving any discrepancies
Collaborate with legal and operations teams to clarify contract ambiguities and gather additional context as needed
Maintain organized records of reviewed contracts and track progress on data migration projects
Qualification
Required
Organized and proficient with data management tools
Strong understanding of contract terminology
Strong attention to detail and ability to handle large volumes of data with high accuracy
Preferred
At least 1 year of experience in contract review, data analysis, or administrative roles strongly preferred
Familiarity with contract terminology and basic legal principles
Proficiency in data entry and management software; experience with Contract Management Systems (e.g., DocuSign CLM, HighQ, or similar) is a plus
Company
NeoGenomics Laboratories
NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and oncology data solutions.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$925.9M2021-05-05Post Ipo Equity· $200M
2020-04-30Post Ipo Equity· $125.4M
2020-04-30Post Ipo Debt· $175M
Leadership Team
Ravi Ada
Chief Technology Officer, Informatics Division
George A. Cardoza
Chief Financial Officer
Recent News
2026-01-04
Company data provided by crunchbase